ISPOR Announces Honorees for 2018 Awards Program

Published Apr 9, 2018

Global Leaders in Health Economics and Outcomes Research Honored

Lawrenceville, NJ, USA—April 9, 2018—ISPOR, the professional society for health economics and outcomes research, announced today the honorees for its 2018 Scientific and Leadership Awards. ISPOR Scientific Awards are designed to foster and recognize excellence and outstanding technical achievement in health economics and outcomes research (HEOR) and its Leadership Awards recognize excellence and outstanding leadership in the field. Avedis Donabedian Lifetime Achievement Award Reed Johnson, PhD is recognized for his outstanding, life-long contribution to the improvement of health outcomes. Dr Johnson is a professor at Duke School of Medicine, Duke Clinical Research Institute, Duke University, Durham, NC, USA. Marilyn Dix Smith Leadership Award Finn Børlum Kristensen, PhD, MD is recognized for his extraordinary leadership to the Society. Dr Børlum Kristensen is is a professor of Health Services Research and Health Technology Assessment at Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark and former secretariat director and chairman of the Executive Committee, European Network for Health Technology Assessment (EUnetHTA). Bernie O’Brien New Investigator Award Sherri Rose, PhD is recognized as an investigator of exceptional promise. Dr Rose is an associate professor at Harvard Medical School, Boston, MA, USA. Value in Health Paper of the Year Award Richard Cookson, PhD receives this award for his outstanding research paper, “Using Cost-Effectiveness Analysis to Address Health Equity Concerns,” published in the February 2017 issue of Value in Health. Dr Cookson is a professor and National Institute for Health Research senior research fellow at the Centre for Health Economics, University of York, York, UK.  Award for Excellence in Health Economics and Outcomes Research Methodology Laura A. Hatfield, PhD is recognized for her outstanding research in the field of health economics and outcomes research methodology. Dr Hatfield is an associate professor of health policy at the Department of Health Care Policy, Harvard Medical School, Boston, MA, USA. Award for Excellence in Health Economics and Outcomes Research Application Rebecca Myerson, MHP, PhD is recognized for her outstanding practical application of health economics and outcomes research in healthcare decision making. Dr Myerson is an assistant professor of pharmaceutical and health economics at the School of Pharmacy and University of Southern California Schaeffer Center for Health Policy and Economics, Los Angeles, CA, USA.

###

ABOUT ISPOR ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field. Web: www.ispor.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: www.twitter.com/ISPORorg (@ISPORorg) | YouTube: www.youtube.com/user/ISPORorg/videos | Facebook: www.facebook.com/ISPORorg | Instagram: www.instagram.com/ISPORorg ABOUT VALUE IN HEALTH Value in Health (ISSN 1098-3015) is an international, indexed journal that publishes original research and health policy articles that advance the field of health economics and outcomes research to help healthcare leaders make evidence-based decisions. The journal’s 2016 impact factor score is 4.235. Value in Health is ranked 3rd out of 77 journals in health policy and services, 7th out of 347 journals in economics, and 9th out of 90 journals in healthcare sciences and services. Value in Health is a monthly publication that circulates to more than 10,000 readers around the world. Web: www.ispor.org/valueinhealth_index.asp | Twitter: www.twitter.com/ISPORJournals (@ISPORjournals)

Related Stories

The Ozempic Paradox: How Spending Billions on Weight-Loss Drug Would Actually Reduce Overall Medicare Costs

Oct 14, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a landmark study by researchers at the University of Washington, Curta, Inc, and the University of North Carolina showing that broad Medicare coverage of semaglutide in diabetes, obesity, and liver disease could generate significant cost savings while delivering substantial health benefits to beneficiaries. The report, “Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare,” was published in the October 2025 issue of Value in Health.

ISPOR Europe 2025 Plenaries and Speakers Announced

Oct 13, 2025

ISPOR announced details for its ISPOR Europe 2025. The conference is the leading global conference in Europe for health economics and outcomes research (HEOR) and is scheduled for 9-12 November in Glasglow, Scotland, UK with the theme, “Powering Value and Access Through Patient-Centered Collaboration.”
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×